Odisha’s First Vaccine Manufacturing Plant ‘Sapigen Biologix’ To Start Production By May 2024

Bhubaneswar: Commercial production at the Sapigen Biologix vaccine plant in Odisha, the first such facility in the state, will commence by May this year, officials said on Sunday.

The plant at the Biotech Park in Andharua near here will have a capacity to produce 2.4 crore doses of different vaccines per day, they said.

At full capacity, this facility will be the biggest vaccine-producing plant in the country, the Chief Minister’s Office (CMO) said in a statement.

It is expected to produce over 15 vaccines for various diseases, including cholera and malaria.

The Rs 1,500-crore vaccine plant will create direct employment for 1,500 people, with most of them being local recruits, the CMO said.

The variety of vaccines produced in Bhubaneswar will be supplied to many parts of the world, it added.

V K Pandian, the chairman of ‘5T’ technology-led transformative initiatives on Sunday visited the sub-units and interacted with the management and employees. He urged all government agencies to assist in the commissioning of the plant within the next three months.

Related Posts

4 arrested in blood plasma adulteration racket

Vehicles carrying plasma were diverted before reaching pharmaceutical companies to a location in Moriya near Ahmedabad Ahmedabad rural police on Monday arrested four persons from Ahmedabad and Mumbai, including a…

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

The latest list features several common medicines such as paracetamol, metformin combos (for diabetes), amoxicillin formulations (antibiotic), vitamin supplements, and cough syrups. New Delhi: During their monthly quality review, the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4 arrested in blood plasma adulteration racket

4 arrested in blood plasma adulteration racket

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions

Stakeholders push for stronger supply chain compliance through GSDP training

Stakeholders push for stronger supply chain compliance through GSDP training

India’s Battle Against Addiction: From Liquor Ban To ‘Dry Drugs’, Bihar’s Youth Trapped In A Growing Narcotics Crisis

India’s Battle Against Addiction: From Liquor Ban To ‘Dry Drugs’, Bihar’s Youth Trapped In A Growing Narcotics Crisis

Ovarian Reserve is ‘Jumping Age’ in Indian Women, SHE Delhi red flags

Ovarian Reserve is ‘Jumping Age’ in Indian Women, SHE Delhi red flags